Filings

6 documents · 26 matches

1. COCP Cocrystal Pharma, Inc. 10-Q 2026-08-13

   Item 6. Exhibits 11

   going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability
   3 matches in this document Show context Copy citation

2. COCP Cocrystal Pharma, Inc. 10-Q 2026-05-15

   Item 6. Exhibits 12

   going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability
   5 matches in this document Show context Copy citation

3. COCP Cocrystal Pharma, Inc. 10-Q 2025-08-14

   Item 6. Exhibits 12

   going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability
   3 matches in this document Show context Copy citation

4. COCP Cocrystal Pharma, Inc. 10-Q 2025-05-15

   Item 6. Exhibits 10

   going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability
   3 matches in this document Show context Copy citation

5. COCP Cocrystal Pharma, Inc. 10-Q 2025-11-14

   Item 6. Exhibits 12

   going concern. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded
   5 matches in this document Show context Copy citation

6. COCP Cocrystal Pharma, Inc. 10-K 2026-03-31

   Item 8. Financial Statements

   going concern. As discussed in Note 1 to the consolidated financial statements, the Company suffered a net loss from operations
   7 matches in this document Show context Copy citation